OPKO Health Stock Forecast, Price & News

OPKO Health (NASDAQ:OPK) Frequently Asked Questions

Is OPKO Health a buy right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for OPKO Health in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" OPKO Health stock.
View analyst ratings for OPKO Health or view top-rated stocks.

How has OPKO Health's stock price been impacted by Coronavirus (COVID-19)?

OPKO Health's stock was trading at $1.69 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, OPK shares have increased by 137.9% and is now trading at $4.02.
View which stocks have been most impacted by COVID-19.

When is OPKO Health's next earnings date?

OPKO Health is scheduled to release its next quarterly earnings announcement on Thursday, February 17th 2022.
View our earnings forecast for OPKO Health.

How were OPKO Health's earnings last quarter?

OPKO Health, Inc. (NASDAQ:OPK) issued its quarterly earnings results on Thursday, October, 28th. The biotechnology company reported $0.04 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.01) by $0.05. The biotechnology company had revenue of $385.80 million for the quarter, compared to analysts' expectations of $302.27 million. OPKO Health had a net margin of 4.06% and a trailing twelve-month return on equity of 4.42%. OPKO Health's revenue was down 9.9% on a year-over-year basis. During the same quarter last year, the company posted $0.04 EPS.
View OPKO Health's earnings history.

What price target have analysts set for OPK?

3 Wall Street analysts have issued 1-year price objectives for OPKO Health's stock. Their forecasts range from $5.00 to $7.00. On average, they anticipate OPKO Health's stock price to reach $6.00 in the next twelve months. This suggests a possible upside of 49.3% from the stock's current price.
View analysts' price targets for OPKO Health or view top-rated stocks among Wall Street analysts.

Who are OPKO Health's key executives?

OPKO Health's management team includes the following people:

• Phillip Frost, Chairman & Chief Executive Officer
• Jon Roger Cohen, Director & Senior Vice President
• Adam E. Logal, CFO, Treasurer, Chief Accounting Officer & SVP
• Jane H. Hsaio, Vice Chairman & Chief Technical Officer
• Steven D. Rubin, Director & Executive Vice President-Administration

What is Philip Frost's approval rating as OPKO Health's CEO?

21 employees have rated OPKO Health CEO Philip Frost on Glassdoor.com. Philip Frost has an approval rating of 16% among OPKO Health's employees. This puts Philip Frost in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of OPKO Health's key competitors?

Some companies that are related to OPKO Health include Amgen (AMGN), Gilead Sciences (GILD), Regeneron Pharmaceuticals (REGN), Vertex Pharmaceuticals (VRTX), Biogen (BIIB), Seagen (SGEN), Alnylam Pharmaceuticals (ALNY), BioMarin Pharmaceutical (BMRN), Incyte (INCY), Exact Sciences (EXAS), Repligen (RGEN), Novavax (NVAX), United Therapeutics (UTHR), Neurocrine Biosciences (NBIX) and Exelixis (EXEL).
View all of OPK's competitors.

What other stocks do shareholders of OPKO Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other OPKO Health investors own include TherapeuticsMD (TXMD), Micron Technology (MU), NVIDIA (NVDA), bluebird bio (BLUE), Gilead Sciences (GILD), Pfizer (PFE), Inovio Pharmaceuticals (INO), Novavax (NVAX), Advanced Micro Devices (AMD) and AT&T (T).

What is OPKO Health's stock symbol?

OPKO Health trades on the NASDAQ under the ticker symbol "OPK."

Who are OPKO Health's major shareholders?

OPKO Health's stock is owned by many different retail and institutional investors. Top institutional shareholders include BlackRock Inc. (5.11%), Geode Capital Management LLC (1.13%), Dimensional Fund Advisors LP (0.66%), Nordea Investment Management AB (0.39%), Invesco Ltd. (0.39%) and Bank of New York Mellon Corp (0.29%). Company insiders that own OPKO Health stock include Anthony J Japour, Jon R Cohen, Phillip Md Et Al Frost, Robert J Shovlin and Steven D Rubin.
View institutional ownership trends for OPKO Health.

Which institutional investors are selling OPKO Health stock?

OPK stock was sold by a variety of institutional investors in the last quarter, including Dimensional Fund Advisors LP, BlackRock Inc., Citigroup Inc., Renaissance Technologies LLC, Morgan Stanley, Two Sigma Advisers LP, Hennion & Walsh Asset Management Inc., and New York State Common Retirement Fund.
View insider buying and selling activity for OPKO Health or view top insider-selling stocks.

Which institutional investors are buying OPKO Health stock?

OPK stock was bought by a variety of institutional investors in the last quarter, including Nordea Investment Management AB, Wolverine Asset Management LLC, Jupiter Asset Management Ltd., Jump Financial LLC, Alliancebernstein L.P., SG Americas Securities LLC, Connor Clark & Lunn Investment Management Ltd., and Rafferty Asset Management LLC. Company insiders that have bought OPKO Health stock in the last two years include Anthony J Japour, Jon R Cohen, Phillip Md Et Al Frost, and Steven D Rubin.
View insider buying and selling activity for OPKO Health or or view top insider-buying stocks.

How do I buy shares of OPKO Health?

Shares of OPK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is OPKO Health's stock price today?

One share of OPK stock can currently be purchased for approximately $4.02.

How much money does OPKO Health make?

OPKO Health has a market capitalization of $2.74 billion and generates $1.44 billion in revenue each year. The biotechnology company earns $30.59 million in net income (profit) each year or $0.11 on an earnings per share basis.

How many employees does OPKO Health have?

OPKO Health employs 5,269 workers across the globe.

What is OPKO Health's official website?

The official website for OPKO Health is www.opko.com.

Where are OPKO Health's headquarters?

OPKO Health is headquartered at 4400 BISCAYNE BLVD., MIAMI FL, 33137.

How can I contact OPKO Health?

OPKO Health's mailing address is 4400 BISCAYNE BLVD., MIAMI FL, 33137. The biotechnology company can be reached via phone at (305) 575-4100, via email at [email protected], or via fax at 305-575-6015.